RAPS and China’s SFDA form regulatory education and training collaboration

Published: 9-Nov-2012

Initial focus will be on medical device regulation

The Regulatory Affairs Professionals Society (RAPS) is to collaborate with China’s State Food and Drug Administration Institute of Executive Development (SFDAIED) on regulatory training and education in China and the US.

RAPS is a global organisation for those involved with the regulation of healthcare and related products, based in Rockville, MD, US. SFDAIED is the branch of China’s SFDA that provides education and training to the country’s regulatory authorities and professionals overseeing food, drugs and other healthcare products.

The two organisations have signed a Memorandum of Understanding and agree that the priority focus area should be on medical devices. They will work together to develop an international workshop on medical device regulation, as well as integrate RAPS’ training programmes into SFDAIED’s and develop training on Chinese medical device regulation for RAPS’ global web-based training programme, RAPS Online University.

‘Healthcare products and medical technology are developed, manufactured and marketed all across the world today. These products and the work that goes into creating them and making them available is not confined within national boundaries, and neither should the best training and resources be for those who regulate them,’ said RAPS’ executive director Sherry Keramidas.

‘This collaboration will help regulatory professionals in industry and government in China and the US to further their regulatory knowledge, building global regulatory capacity that can help improve public health for the people of both nations and beyond.’

You may also like